Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
Funding for advancing the knowledge on 2019-nCoV and its impact on infected persons, with the aim of contributing to an efficient patient management and/or public health preparedness and response. Proposals must be timely, with rapid activation, to enable early and valuable outcomes to be established.
Característiques principals
Considering that this is a newly identified virus, the scope of this expression of interest remains broad and may include topics such as:
  • Development of therapeutics, including monoclonal antibodies. As relevant, evidence of regulatory and ethics approvals for the investigational products included in the study(ies) must be presented.
  • Development of point of care diagnostics, ensuring rapid evaluation of candidates based on existing technologies, to allow for fast case detection and surveillance.
  • Clinical and epidemiological studies, to provide data on epidemiological characteristics such as viral genotype and pathogenicity; clinical information on host susceptibility and host immune responses; risk factors for severe disease; routes of transmission and their relative importance; identification of the animal reservoir; etc.
  • Social sciences research, to provide urgently needed answers to social dynamics of the outbreak and the related public health response.
    • Lloc de presentació
    El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
    Servei de Recerca. C/ Doctor Aiguader, 88. 08003-Barcelona. Tel.: 93.316.04.00.
    Carol Barnwell: [email protected] Ext.1670
    Marta López: [email protected], Ext.: 1576
    Convocatòria (URL)
    https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/sc1-phe-coronavirus-2020;freeTextSearchKeyword=;typeCodes=1;statusCodes=31094502;programCode=H2020;programDivisionCode=31047894;focusAreaCode=null;cross=
    Requisits
    Eligibility:
  • Entities established in the Member States of the European Unión. Entities from other countries may be also eligible for funding. Please see annex A of the Work Programme.
  • Mínimum of three legal entities. Each of the three shall be established in a different Member State or associated country. All three legal entities shall be independent of each other.
    • Dotació
    Between EUR 2 and 3 million

    Arxius

    Arxiu
    h2020-wp1820-health_en (20).pdf